Keywords: drug reaction; gp100; granuloma; granulomatous reaction; immunotherapy; interleukin-2; melanoma; melanoma-associated antigen 3; resiquimod; IL-2; interleukin-2 (); MAGE-3; melanoma-associated antigen 3 ();
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Allergic rhinitis; TLR7/8; Resiquimod; IL-25; IL-33; TIM3;
Keywords: Resiquimod; R-848; Adjuvant; Mucosal immunity; IgA; Infectious bronchitis virus; Chicken;
Keywords: actinic keratosis; basal cell carcinoma; Bowen disease; erythroplasia of Queyrat; lentigo maligna; melanoma; Paget disease; skin cancer; squamous cell carcinoma; topical treatment; 5-FU; 5-fluorouracil; AK; actinic keratosis; BCC; basal cell carcinoma; B
IL-1β induces expression of costimulatory molecules and cytokines but not immune feedback regulators in dendritic cells
Keywords: Dendritic cell; IL-1β; Microbial stimulation; Feedback regulation; APC; Antigen-presenting cell; DC; Dendritic cell; HCA; Heat-inactivated Candida albicans extract; IFN; Interferon; IL-1β; Interleukin-1β; IL-1RA; Interleukin-1 receptor antagonist; LDH;
Functionalized PLA polymers to control loading and/or release properties of drug-loaded nanoparticles
Keywords: Microwave-assisted ROP; Functionalized PLA; Drug loading; In vitro drug release; Resiquimod;
Synergistic effect of co-stimulation of membrane and endosomal TLRs on chicken innate immune responses
Keywords: TLR; toll like receptor; TLR-Ls; toll-like receptor ligands; BMMs; bone marrow-derived macrophages; PCSK; pam3Cys-SK4; MPLA; synthetic monophosphoryl lipid A; KLA; Di[3-deoxy-d-manno-octulosonyl]-lipid A ammonium salt; R848; resiquimod; CpG; cytosine-phos
Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation
Keywords: Nanoparticle; Immunostimulation; Resiquimod; TLR7;
A high-resolution mass cytometry analysis reveals a delay of cytokines production after TLR4 or TLR7/8 engagements in HIV-1 infected humans
Keywords: TLR; toll-like receptors; HIV; human immunodeficiency virus; PAMP; pathogen-associated molecular patterns; LPS; lipopolysaccharides; Poly(I:C); polyinosinic: polycytidylic acid; R848; resiquimod; SPADE; spanning-tree progression analysis of density-normal
Prophylactic potential of resiquimod against very virulent infectious bursal disease virus (vvIBDV) challenge in the chicken
Keywords: Toll-like receptors; Prophylaxis; Real time PCR; Infectious bursal disease; Resiquimod; Immune response genes; Chicken
Administration of TLR7 agonist, resiquimod, in different types of chicken induces a mixed Th1 and Th2 response in the peripheral blood mononuclear cells
Keywords: Toll-like receptors; Resiquimod; Chicken; PBMCs; Immune response genes;
Synergy of lipopolysaccharide and resiquimod on type I interferon, pro-inflammatory cytokine, Th1 and Th2 response in chicken peripheral blood mononuclear cells
Keywords: Toll-like receptor; Lipopolysaccharide; Resiquimod; Cytokine; Adjuvant; Chicken PBMCs; Cross-talk; Synergism; Nitric oxide; Inducible nitric oxide synthase;
Adjuvant potential of resiquimod with inactivated Newcastle disease vaccine and its mechanism of action in chicken
Keywords: Chicken; TLR agonist; Resiquimod; Adjuvant; Newcastle disease; Immune response genes; Cytokines;
Single-cell systems-level analysis of human Toll-like receptor activation defines a chemokine signature in patients with systemic lupus erythematosus
Keywords: Mass cytometry; Toll-like receptors; systemic lupus erythematosus; inflammation; monocytes; monocyte chemotactic protein 1; CD1c+ DC; Conventional dendritic cell; CREB; cAMP response element-binding protein; MCP-1; Monocyte chemotactic protein 1; MIP-1Î
Pattern recognition receptor-mediated cytokine response in infants across 4 continentsâ
Keywords: Innate immunity; immune development; infectious disease; global; LPS; Lipopolysaccharide; MDP; Muramyl dipeptide; NOD; Nucleotide-binding oligomerization domain-containing protein; PCA; Principal-component analysis; PGN; Peptidoglycan; Poly I:C; Polyinosi
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
Keywords: DC; dendritic cell; LN; lymph node; ODN; oligonucleotide; PAMP; pathogen-associated molecular pattern; PAP; prostatic acid phosphatase; PO; phosphodiester; PS; phosphorothioate; PRR; pattern recognition receptor; SVP; synthetic vaccine particle; Tfh; foll
TLR7/8 agonists trigger immunostimulatory properties of human 6-sulfo LacNAc dendritic cells
Keywords: Dendritic cells; Resiquimod; Imiquimod; Tumor immunology; Immunotherapy
Targeted antigen delivery and activation of dendritic cells in vivo: Steps towards cost effective vaccines
Keywords: APC; antigen presenting cell; cDC; conventional dendritic cell; CLR; C type lectin receptor; DC; dendritic cell; FcR; Fc receptor; IFN; interferon; LC; Langerhans cell; MPL; monophosphoryl lipid A; MR; mannose receptor; NLR; NOD-like receptor; NLRP3; NLR
Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production
Keywords: TLR-7; resiquimod; naive human B cells; immunoglobulin class-switch recombination; X-linked hyper-IgM syndrome; AID; Activation-induced cytidine deaminase; APC; Allophycocyanin; BAFF; B cell-activating factor of TNF family; BCR; B-cell receptor; CSR; Cl
Oral resiquimod in chronic HCV infection: Safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies
Keywords: Resiquimod; Hepatitis C virus; Toll-like receptor; TLR7 agonist; TLR8 agonist; Clinical trial; Treatment; Pharmacokinetics; Pharmacodynamics